Kazumi Hyoudou

Title: Kazumi Hyoudou: Innovator in Medicinal Chemistry

Introduction

Kazumi Hyoudou is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of medicinal chemistry, particularly in the treatment of porphyria. Her innovative approach has led to the development of a unique therapeutic agent that addresses this rare condition.

Latest Patents

Kazumi Hyoudou holds a patent for a prophylactic or therapeutic agent for porphyria. The patent describes a medicament for the treatment or prevention of porphyria, comprising 1-{2-[(3S,4R)-1-{[(3R,4R)-1-cyclopentyl-3-fluoro-4-(4-methoxyphenyl)pyrrolidin-3-yl]carbonyl}-4-(methoxymethyl)pyrrolidin-3-yl]-5-(trifluoromethyl)phenyl}piperidine-4-carboxylic acid or a pharmaceutically acceptable salt or cocrystal thereof as an active ingredient. The recommended dosage of this compound is between 50 to 500 mg per day.

Career Highlights

Kazumi Hyoudou is currently employed at Tanabe Pharma Corporation, where she continues to advance her research in medicinal chemistry. Her work has been instrumental in developing new treatments that improve patient outcomes in the field of porphyria.

Collaborations

Kazumi has collaborated with notable colleagues, including Tsuyoshi Suzuki and Masahiro Kondo. These partnerships have fostered a collaborative environment that enhances innovation and research in their respective fields.

Conclusion

Kazumi Hyoudou's contributions to medicinal chemistry, particularly through her patent for a therapeutic agent for porphyria, highlight her role as an influential inventor. Her work at Tanabe Pharma Corporation and collaborations with esteemed colleagues further underscore her commitment to advancing healthcare solutions.